from THCB at http://bit.ly/2JErCWC on April 30, 2018 at 09:24PM By TIMOTHY HOFF “Value” is the focus right now in American health care. Payers like Medicare and private insurers are placing great emphasis on it, as are hospitals and doctors’ offices needing to satisfy the demands of those payers to get paid. But the focus […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2FtVd2K on April 30, 2018 at 07:25PM A group of experts during the Academy of Managed Care Pharmacy’s annual meeting in Boston discussed the ongoing evolution of communication between manufacturers and payers. The presentation was conducted by: Jay Jackson, Xcenda senior vice president of consulting services; Kat Wolf […]
from The Incidental Economist at http://bit.ly/2HHD5Ec on April 30, 2018 at 06:06PM As you know, I’m now the Web and Social Media Editor at JAMA Pediatrics. We’ve got a podcast where I discuss a paper from the journal. I do my best to pick good ones. Please consider giving this a listen, and subscribe! Doing so […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HC3OpS on April 30, 2018 at 05:55PM The Center for Biosimilars published what it says are the top seven memorable quotes from the Alliance for Patient Access Annual National Policy and Advocacy Summit on Biologics and Biosimilars. The summit was held April 17 in Washington. Below are several […]
from Health Economics at http://bit.ly/2HDy9QL on April 30, 2018 at 04:55PM Empirical evidence on the employment effects of minimum wage legislation suggests the possibility that firms react to increases in low-skilled labor costs driven by minimum wages by reducing investments in non-wage job aspects, which can mitigate the need for layoffs. Such adjustments may involve […]
from Health Economics at http://bit.ly/2jj1s0k on April 30, 2018 at 04:55PM Background: The rising prevalence of dementia represents an important public health issue. There is currently no available cure for dementia disorders, only symptom-relieving therapies which can be either pharmacological or non-pharmacological. The number of non-pharmacological interventions for patients with dementia disorders and their caregivers […]
from Health Economics at http://bit.ly/2HGAGcZ on April 30, 2018 at 04:55PM This article was championed in view of the notion of (perceived) economic rationalisation which seem to be the foremost of patients’ care in the NHS as opposed to addressing distress to their existing well-being, while in a state of being tormented with agonising news […]
from Health Economics at http://bit.ly/2I0J8Hz on April 30, 2018 at 04:55PM The Ruth L. Kirschstein National Research Service Award (NRSA) program is a major research training program administered by the National Institutes of Health (NIH) with funds appropriated each year by Congress. This study examines the impact of NRSA postdoctoral fellowships on subsequent research-related career […]
from Health Economics at http://bit.ly/2HEeAb4 on April 30, 2018 at 04:55PM This study provides the first evidence on the effects of U.S. state-level private and public insurance expansions on specialty substance use disorder (SUD) treatment use among children ages 12 to 18. We examine both private and public expansions over the period 1996 to 2010. […]
from Health Economics at http://bit.ly/2jjyJsw on April 30, 2018 at 04:55PM This paper examines the impacts of the Affordable Care Act (ACA) – which substantially increased insurance coverage through regulations, mandates, subsidies, and Medicaid expansions – on behaviors related to future health risks after three years. Using data from the Behavioral Risk Factor Surveillance System […]
from Health Economics at http://bit.ly/2HJ91s1 on April 30, 2018 at 04:55PM The conventional method for developing health care plan payment systems uses existing data to study alternative algorithms with the purpose of creating incentives for an efficient and fair health care system. In this paper, we take a different approach and modify the input data […]
from Health Economics at http://bit.ly/2I0J2zH on April 30, 2018 at 04:55PM Disability benefit recipients in the United States have nearly doubled in the past two decades, growing substantially faster than the population. It is difficult to estimate how much of this increase is explained by changes in population health, as we often lack a valid […]
from Health Economics at http://bit.ly/2HJ8XbL on April 30, 2018 at 04:55PM We study the effect of two local immigration enforcement policies – Section 287(g) of the Illegal Immigration Reform and Immigrant Responsibility Act and the Secure Communities Program (SC) – that have escalated fear and risk of deportation among the undocumented on the health and […]
from Health Economics at http://bit.ly/2jg0MZE on April 30, 2018 at 04:55PM Cesarean delivery for low-risk pregnancies is generally associated with worse health outcomes for infants and mothers. The interpretation of this correlation, however, is confounded by potential selectivity in the choice of birth mode. We use birth records from California, merged with hospital and emergency […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2KpVeYY on April 30, 2018 at 04:54PM ZOOM+Care recently announced an ACO commercial product in partnership with Aetna for Portland, Oregon, employers. The announcement was made April 25. According to a Becker’s Hospital Review report, Aetna through the plan will reward ZOOM+Care providers for achieving a broad range […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2FtFr7P on April 30, 2018 at 04:54PM Despite pharmacy benefit managers posting slow drug spending growth in 2017, patients and employers are still carrying a tremendous amount of cost burden, National Pharmaceutical Council President Dan Leonard says. PBM Prime Therapeutics also brought down costs year over year. “Unfortunately, […]
from RAND Research Topic: Health and Health Care at http://bit.ly/2FvQ0Ho on April 30, 2018 at 04:32PM This issue features research on preventing child abuse and neglect and improving outcomes for children in the U.S. child-welfare system; a look back on RAND’s 70 years of innovation; and an exploration of the human side of artificial intelligence.
from The Academic Health Economists’ Blo… at http://bit.ly/2w1rgYl on April 30, 2018 at 04:31PM Every Monday our authors provide a round-up of some of the most recently published peer reviewed articles from the field. We don’t cover everything, or even what’s most important – just a few papers that have interested the author. Visit our […]
from PharmacoEconomics at http://bit.ly/2vU1HIu on April 30, 2018 at 03:15PM Abstract Background Exemestane (EXE), exemestane + everolimus (EXE + EVE), toremifene (TOR), and fulvestrant (FUL) are second-line endocrine therapies for postmenopausal hormone receptor–positive (HR +)/human epidermal growth factor receptor 2–negative (HER2 −) metastatic breast cancer (mBC) in Japan. Although the efficacy of these therapies has been shown in recent studies, cost-effectiveness […]
from Market Design at http://bit.ly/2JEGTqC on April 30, 2018 at 01:17PM College waiting lists are a bit of a misnomer–they aren’t ordered lists, they are more like waiting pools from which candidates can be drawn if the yield from regular admissions falls short. The WSJ has the story:College Wait Lists Are Ballooning as Schools Struggle […]
from International Journal of Health Economics and Management at http://bit.ly/2HCXoXF on April 30, 2018 at 08:18AM Abstract Many studies have found that health outcomes decline when health professionals leave the country, but do such results remain consistent in gender- and income-disaggregated skilled migration? To help uncover explanations for such a pro-migration nature of health outcomes, […]
from Health Economics and Decision Science Blog @ ScHARR at http://bit.ly/2HDIlZv on April 30, 2018 at 07:30AM … published since our last update in January are listed below. The MIBs review relevant published evidence and the likely costs of new technologies. They are designed to be fast, flexible and responsive to the need for information […]
from THCB at http://bit.ly/2jiuVrk on April 30, 2018 at 06:16AM Jessica DaMassa asks me about the biggest IPO in Digital Health ever, the Platform vs App question and what was Seema Verma tweeting about during #HDPalooza. All in 2 minutes–Matthew Holt
from Healthcare Economist at http://bit.ly/2FsTpXE on April 30, 2018 at 03:34AM Drugs known as “orphan” drugs are those used to treat rare disease. However, how “rare” is rare disease? In Europe, a rare disease is one affecting 5 or fewer people per 10,000 residents. In the U.S. this figure is less than one in every […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2KpANvu on April 29, 2018 at 07:51PM Dr. Patti Peeples, HealthEconomics.Com founder, will present during a live and exclusive May 9 web event never-before-seen insights from the 2017 Global Salary Survey Report. The webinar kicks off noon May 9. Only $50 can earn you access to inside information […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2jewS8d on April 29, 2018 at 06:21PM A recent study by the National Health Council Value Workgroup found several emerging good practices for patient engagement in value assessment frameworks. According a survey conducted by the group, emerging practices included: engage early; engage a range of patients; leverage patient-provided […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2r8wiwi on April 29, 2018 at 05:51PM A new report from the Council of Accountable Physician Practice (CAPP) lays out a roadmap for the U.S. health care system’s transition to a value-based payment system. According to an American Journal of Managed Care report, the primer is the […]
from Market Design at http://bit.ly/2rdmDov on April 29, 2018 at 01:18PM A bill introduced in Hong Kong clarifies that kidney exchange doesn’t count as (forbidden) "inducement" to donate an organ under the law. (In this respect the bill seems to parallel the Norwood Act which amended the U.S. National Organ Transplant Act for the same […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2w3FJmH on April 28, 2018 at 06:18PM The Institute for Clinical and Economic Review (ICER) has posted a Draft Scoping Document outlining a planned review of the comparative clinical effectiveness and value of several newer options for medication-assisted treatment (MAT) of opioid use disorder. The scoping document will […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2r62UaH on April 28, 2018 at 06:18PM U.S. payers will need significant amounts of data if the U.S. health care system is going to bring about an age of value-based care, according to an article published April 23 on Healthcare Analytics News. The authors, Carl Schneider and Roma […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HEhoF4 on April 28, 2018 at 05:48PM IQVIA Vice President of Industry Relations Douglas Long discussed some of the current trends in the pharmaceutical market during the Academy of Managed Care Pharmacy’s annual meeting in Boston. According to an AMCP report, drug spending in the U.S. reached some […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HXceaz on April 28, 2018 at 05:48PM Michelle Drozd, deputy vice president of PhRMA’s Policy and Research department, says value-based contracts can help cut out-of-pocket costs and grant patients access to “the right treatments the first time.” “Recent criticisms of value-based contracts — or results-based contracts — are […]
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HylItB on April 28, 2018 at 05:18PM The Institute for Clinical and Economic Review (ICER) on Friday released a Draft Evidence Report assessing the comparative clinical effectiveness and value of treatments for moderate-to-severe plaque psoriasis. The review will be open to public comment until May 25. Findings contained […]
from Market Design at http://bit.ly/2vPj39o on April 28, 2018 at 01:37PM I don’t know how big of an issue it is, but this story on ticket scalping was prominently displayed in the South China Morning Post the other day: Touts snap up tickets as Hong Kong fans queue overnight for chance to see Dayo Wong. […]
from The Incidental Economist at http://bit.ly/2w37LPd on April 28, 2018 at 12:01PM I’m going to spend May and July (with a break in between) learning about the history of The Civil War. Since there are two months, I’ll read more than ususl. You’ve already given me some great ideas. I want to post them here, so you […]
from Social Science & Medicine at http://bit.ly/2r3Qy3c on April 28, 2018 at 09:12AM Publication date: Available online 28 April 2018 Source:Social Science & Medicine Author(s): Angus Deaton, Nancy Cartwright
from Social Science & Medicine at http://bit.ly/2Jw2D84 on April 28, 2018 at 09:12AM Publication date: Available online 28 April 2018 Source:Social Science & Medicine Author(s): Worawan Chandoevwit, Phasith Phatchana The Thai elderly are eligible for the Civil Servant Medical Benefit Scheme (CS) or Universal Coverage Scheme (UCS) depending on their pre-retirement or their children work […]
from Social Science & Medicine at http://bit.ly/2jeh45h on April 28, 2018 at 09:12AM Publication date: Available online 27 April 2018 Source:Social Science & Medicine Author(s): Augustine Adomah-Afari, Jim A. Chandler Governments of many developing countries, including those in Sub-Saharan Africa have embraced the community-based health insurance schemes phenomenon under the health sector reforms with optimism. […]
from Social Science & Medicine at http://bit.ly/2JyavFR on April 28, 2018 at 09:12AM Publication date: Available online 27 April 2018 Source:Social Science & Medicine Author(s): Mary Schooling
from tHEORetically Speaking: The HealthEconomics.Com Blog at http://bit.ly/2HvYVi6 on April 27, 2018 at 05:36PM Kentucky-based Humana on Wednesday announced its launch of a new value-based payment program with hospitals, the Hospital Incentive Program. The program, according to a Fierce Healthcare report, aims to bring down duplicative services and hospital readmissions, both of which can prove […]
Health Econ Bot 
You must be logged in to post a comment.